4//SEC Filing
Tobira Therapeutics, Inc. 4
Accession 0001140361-16-083089
CIK 0001311596operating
Filed
Oct 18, 8:00 PM ET
Accepted
Oct 19, 5:00 PM ET
Size
8.5 KB
Accession
0001140361-16-083089
Insider Transaction Report
Form 4
Pentwater Capital Management LP
10% Owner
Transactions
- Purchase
Common Stock, par value $0.001 per share
2016-10-18$40.04/sh+8,300$332,332→ 3,743,200 total(indirect: By managed account) - Purchase
Common Stock, par value $0.001 per share
2016-10-17$40.10/sh+27,400$1,098,740→ 3,734,900 total(indirect: By managed account) - Purchase
Common Stock, par value $0.001 per share
2016-10-17$39.89/sh+4,300$171,527→ 3,707,500 total(indirect: By managed account)
Footnotes (1)
- [F1]The reporting person is the investment manager for PWCM Master Fund Ltd, an exempted company formed in the Cayman Islands, Pentwater Equity Opportunities Master Fund, Ltd., an exempted company formed in the Cayman Islands, Oceana Master Fund, Ltd., an exempted company formed in the Cayman Islands, Amundi Absolute Return Pentwater Fund Plc, a private fund formed in Ireland, Pentwater Event Driven Cayman Fund Limited, an exempted company formed in the Cayman Islands, Pentwater Merger Arbitrage Master Fund LTD, an exempted company formed in the Cayman Islands, and LMA SPC for and on behalf of MAP 98 Segregated Portfolio, a segregated portfolio company formed in the Cayman Islands, which directly own the shares.
Documents
Issuer
Tobira Therapeutics, Inc.
CIK 0001311596
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001311596
Filing Metadata
- Form type
- 4
- Filed
- Oct 18, 8:00 PM ET
- Accepted
- Oct 19, 5:00 PM ET
- Size
- 8.5 KB